OVERVIEW

Bladder Tumors, Renal Masses, Ovarian Tumors, and Uterine Neoplasms is organized by United States and Canadian Academy of Pathology (USCAP).

Original release date: April 16, 2017 
Access to this course expires: July 23, 2019

Target Audience:
Practicing academic and community pathologists, and pathologists-in-training.

CME / SAM: 9.0

Course Description:
Especially valuable to surgical pathologists and cytopathologists alike, the latest updates on noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) will help ensure that a subset of indolent thyroid tumors is managed more conservatively and spares patients the anxiety of a cancer diagnosis. The activity will help pathologists and cytopathologists minimize malignant diagnoses on cytology associated with a final diagnosis of NIFTP and identify potential NIFTPs in indeterminate aspirates to promote conservative surgical management.

Learning Objectives:
• Review bladder histology pertinent to diagnosis and stage of bladder cancer 
• Learn to diagnose papillary and flat urothelial neoplasia, glandular lesions, and variants of urothelial carcinoma 
• Learn to diagnose bladder tumor invasion and evaluate depth of invasion 
• Develop a morphology-based differential diagnosis of neoplastic diseases in renal biopsy 
• Understand the utility and limitation of immunohistochemical markers in the diagnosis of bladder and renal tumors

Additional details will be posted as soon as they are available.

Credits
  • 9 CME
  • SPECIALITIES

    OncologyOBGYN and Womens Health

    RELATED ONLINE COURSES

    May 25, 2022 - Nov 30, 2026 | Webcast

    State required course for Connecticut ...
    5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$180

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$15.20

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$102